Home > Press > Nanoethics – the watchdog of a new technology?
First issue of the new journal NanoEthics examines ethical controversies surrounding nanotechnology
Nanoethics – the watchdog of a new technology?
Heidelberg/New York | Posted on June 21st, 2007
The field of nanotechnology is broad and has the potential to be used in a wide range of industries and fields, but the question is whether it is a good investment. Will it solve fundamental social problems that assure a better future? In an article just published in the debut issue of the journal NanoEthics entitled, "Ethics and Technology ‘in the Making': An essay on the Challenge of Nanoethics," an expert discusses how nanoethicists can be among the actors who shape the meaning and materiality of an emerging technology. The first issue of NanoEthics is available online free of charge at
NanoEthics: Ethics for Technologies that Converge at the Nanoscale provides a multidisciplinary forum for exploration of ethical issues related to nanotechnology. It contains a philosophically and scientifically rigorous examination of both the ethical and societal considerations as well as the public and policy concerns inherent in nanotechnology research and development. The journal is of interest to researchers, scholars and students as well as scientific and technological policymakers and decision-makers in corporations involved in nanotechnology.
Editor-in-Chief John Weckert of the Centre for Applied Philosophy and Public Ethics, part of Charles Sturt University, ANU and the University of Melbourne, said, "Not only are the impacts or likely impacts of nanotechnologies the subject matter of this journal, but so are the uncertainties about nanoethics. Nanotechnologies encourage examination, or reexamination, of some basic issues in the ethics and philosophy of technology and science. This journal will help stimulate these discussions."
NanoEthics will be published three times a year online and in print. The journal is available on Springer's online platform www.springerlink.com and includes Online First™, Cross Reference Linking, and Alert services. In addition, all NanoEthics authors, via the Springer Open Choice program, have the option of publishing their articles using the open access publishing model.
Springer is the second-largest publisher of journals in the science, technology, and medicine (STM) sector and the largest publisher of STM books. Springer is part of Springer Science+Business Media, one of the world’s leading suppliers of scientific and specialist literature. The group publishes over 1,700 journals and more than 5,500 new books a year, as well as the largest STM eBook Collection worldwide. Springer has operations in over 20 countries in Europe, the USA, and Asia, and some 5,000 employees.
The first issue of the journal can be viewed free of charge at
Sample copies are available on request.
For more information, please click here
Copyright © Springer
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
PETA science consortium to present at Society for Risk Analysis meeting December 10th, 2014
PETA science consortium experts to present at international nanotechology workshop: PETA International Science Consortium, Ltd., Is a Sponsor of Nano Risk Analysis II September 12th, 2014
PETA science consortium to present hazard testing strategy at nanotoxicology meeting: High tech field ripe for use of sophisticated non-animal testing strategies April 22nd, 2014
Scientists disagree on responsible research April 8th, 2014
New method allows for greater variation in band gap tunability: The method can change a material's electronic band gap by up to 200 percent January 31st, 2015
Evidence mounts for quantum criticality theory: Findings bolster theory that quantum fluctuations drive strange electronic phenomena January 30th, 2015
Everything You Need To Know About Nanopesticides January 30th, 2015
DNA nanoswitches reveal how life's molecules connect: An accessible new way to study molecular interactions could lower cost and time associated with discovering new drugs January 30th, 2015